{"id":3312,"date":"2019-11-16T12:16:00","date_gmt":"2019-11-16T12:16:00","guid":{"rendered":"http:\/\/eurojournalists.com\/?guid=0d579e162cdf80f0669d09a5b1ffa16f"},"modified":"2019-11-16T12:16:00","modified_gmt":"2019-11-16T12:16:00","slug":"novartis-eyes-1b-sales-with-fda-nod-for-targeted-sickle-cell-disease-drug-adakveo-fiercepharma","status":"publish","type":"post","link":"https:\/\/eurojournalists.com\/?p=3312","title":{"rendered":"Novartis eyes $1B sales with FDA nod for targeted sickle cell disease drug Adakveo &#8211; FiercePharma"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/__i\/rss\/rd\/articles\/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25vdmFydGlzLXdpbnMtZmRhLW5vZC1mb3ItdGFyZ2V0ZWQtc2lja2xlLWNlbGwtZGlzZWFzZS1kcnVnLWFkYWt2ZW8tYS1ibG9ja2J1c3Rlci1ob3BlZnVs0gEA?oc=5\" >Novartis eyes $1B sales with FDA nod for targeted sickle cell disease drug Adakveo<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FiercePharma<\/font><strong><a href=\"https:\/\/news.google.com\/stories\/CAAqbQgKImdDQklTUnpvSmMzUnZjbmt0TXpZd1Nqb0tFUWlHcS1hNWpvQU1FWU13UnNZaFI3SU5FaVZWVXlCaGNIQnliM1psY3lCT2IzWmhjblJwY3lCemFXTnJiR1VnWTJWc2JDQmtjblZuS0FBUAE?oc=5\" >View full coverage on Google News<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novartis eyes $1B sales with FDA nod for targeted sickle cell disease drug Adakveo&nbsp;&nbsp;FiercePharmaView full coverage on Google News<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-3312","post","type-post","status-publish","format-standard","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/3312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3312"}],"version-history":[{"count":2,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/3312\/revisions"}],"predecessor-version":[{"id":3441,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/3312\/revisions\/3441"}],"wp:attachment":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}